Top Markets
#1 龙虾 (Lobster) 龙虾 (Lobster) +113.59%
#2 Lisk Lisk +66.16%
#3 Not in Employment, Education, or Training Not in Employment, Education, or Training +27.43%
#4 Alchemist AI Alchemist AI +26.48%
#5 Nockchain Nockchain +25.73%
#6 earnAUSD earnAUSD +24.75%
#7 Illuvium Illuvium +23.62%
#8 Renzo Renzo +22.17%
#9 Akedo Akedo +18.35%
#10 The Black Bull The Black Bull +17.62%
Coin of the day
龙虾 (Lobster) 龙虾 (Lobster)
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
MultiCell Technologies, Inc. MultiCell Technologies, Inc.

MultiCell Technologies, Inc.

MCET
Classificação em ações #41009
MultiCell Technologies, Inc. (MCET) operates as a biopharmaceutical firm,... MultiCell Technologies, Inc. (MCET) operates as a biopharmaceutical firm, primarily focused on the creation of innovative therapeutic agents and research tools. Their efforts are directed towards addressing a range of medical challenges, including neurological conditions, liver ailments, various types of cancer, and applications within interventional cardiology and peripheral vascular health. The company's product pipeline features several key developments: MCT-125: This investigational therapy is currently in Phase II clinical trials, targeting the primary fatigue commonly associated with multiple sclerosis. MCT-465: A preclinical-stage synthetic double-stranded RNA (dsRNA) candidate, designed to act as a powerful immune enhancer for the treatment of solid tumor malignancies. MCT-485: Another dsRNA therapeutic, still in the discovery phase, which demonstrates tumor cytolytic (cell-destroying) properties, intended for use against diverse cancers. Beyond drug candidates, MultiCell Technologies is also progressing the Ideal BioStent, an innovative bioabsorbable stent specifically engineered for use in interventional cardiology and peripheral vessel procedures. The organization maintains licensing agreements with prominent entities such as Corning Incorporated and Pfizer Inc. Established in 1962, the company was previously known as Exten Industries, Inc. before officially changing its name to MultiCell Technologies, Inc. in April 2004. Its corporate headquarters are situated in Woonsocket, Rhode Island.
Preço da ação
$0.00001
Última sincronização: 2026-09-10
Valor de mercado
$50.01K
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar MultiCell Technologies, Inc. (MCET)

Categoria

Healthcare
Histórico de dividendos de MultiCell Technologies, Inc. (MCET)
MultiCell Technologies, Inc. (símbolo da ação: MCET) realizou um total de 0 pagamentos de dividendos.
A soma de todos os dividendos (ajustada para desdobramentos de ações) é: 0.00
Rendimento de dividendos (TTM): 0
Pagamentos de dividendos de MultiCell Technologies, Inc. (MCET) de 2026 a 2026
Pagamentos anuais de dividendos
Ano Dividendo (ajustado para desdobramentos) Alterar
Não há dados suficientes para as datas fornecidas.
Lista de todos os pagamentos de dividendos
Ano Dividendo Alterar
Não há dados suficientes para as datas fornecidas.
Dividendos de empresas semelhantes ou concorrentes
Empresa Número de pagamentos de dividendos País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH